Catalyst Pharmaceuticals
CPRX
#3987
Rank
A$4.35 B
Marketcap
A$35.42
Share price
1.95%
Change (1 day)
5.29%
Change (1 year)

Earnings for Catalyst Pharmaceuticals (CPRX)

Earnings in 2025 (TTM): A$0.44 Billion

According to Catalyst Pharmaceuticals's latest financial reports the company's current earnings are A$0.57 Billion. In 2024 the company made an earning of A$0.32 Billion, an increase over its 2023 earnings that were of A$0.14 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Catalyst Pharmaceuticals from 2007 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$0.44 B37.07%
2024 A$0.32 B128.82%
2023 A$0.14 B-9.75%
2022 A$0.15 B98.83%
2021 A$79.29 M25.73%
2020 A$63.06 M25.38%
2019 A$50.29 M-198.25%
2018 -A$51.2 Million84.68%
2017 -A$27.72 Million1.88%
2016 -A$27.21 Million-10.68%
2015 -A$30.47 Million30.46%
2014 -A$23.35 Million27.6%
2013 -A$18.3 Million198.17%
2012 -A$6.14 Million-36.22%
2011 -A$9.63 Million59.52%
2010 -A$6.04 Million-44.68%
2009 -A$10.91 Million-31.45%
2008 -A$15.91 Million155.21%
2007 -A$6.24 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
BioMarin Pharmaceutical
BMRN
A$1.02 B 137.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-A$0.38 Billion-188.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$48.77 B 11,235.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-A$0.41 Billion-195.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$17.84 B 4,047.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$12.25 B 2,747.50%๐Ÿ‡บ๐Ÿ‡ธ USA